FAQ/Help |
Calendar |
Search |
Today's Posts |
10-28-2016, 10:01 AM | #1 | ||
|
|||
Senior Member
|
Has anyone else noticed how slow the Tagisna trial process for PD is moving but how fast it is moving for Alz? This is so frustrating! Moussa's work at Georgetown was done on PD, he's talked about a bigger trial for PD, Fox has talked about a Tagisna trial for PD, as have others...but these trials have gotten pushed back for over a year. Even now I cannot find where the trial sites will be, when recruitment will begin, what the criteria will be, nothing.
Meanwhile, the FDA has apparently approved a clinical trial of Tasigna for Alz. and the trial is schedule to begin THIS YEAR: Alzheimer's Study Funded by ADDF to Test Cancer Treatment in Patients What's up with this? |
||
Reply With Quote |
"Thanks for this!" says: |
10-28-2016, 10:27 AM | #2 | ||
|
|||
Member
|
Quote:
There is also a third trial that you may want to follow. A small biotech company, Inhibikase Therapeutics, has received FDA approval to begin a double-blinded, placebo-controlled trials for Nilotinib and Dasatinib (Sprycel - Bristol-Myers). The trials will try to evaluate the ability of both drugs (vs placebo) to slow or reverse progression in Stage 2 and 3 PD patients. It will be held at one test site over a 6 month period. The reason Inhibikase is conducting the studies is really more of a proof of concept for two new drugs that they are researching. They are developing two Abelson tyrosine inhibitors that are as much as 60 times more potent than the ones currently on the market (Nilotinib, Dasatinib, Gleevec, etc.). Last edited by Tupelo3; 10-28-2016 at 11:09 AM. |
||
Reply With Quote |
10-28-2016, 07:36 PM | #3 | ||
|
|||
Senior Member
|
I guess that's my point: all these PD orgs out there, many of them huge, and not one of them could fund a trial for Tasigna? They couldn't team up if they didn't want to put all of those research dollars in one basket?
The trials have already been pushed back once that I read about, who knows what really happens behind closed research doors. I have read politics/power were involved between the Fox/GMU that caused that split, and thus we lost valuable time with them doing a PD trial, which is even more frustrating. We are following the Gleevec/Tasigna second generation drugs, thanks! |
||
Reply With Quote |
"Thanks for this!" says: | olsen (11-01-2016) |
10-28-2016, 08:54 PM | #4 | ||
|
|||
Member
|
[QUOTE=lurkingforacure;1227497]I guess that's my point: all these PD orgs out there, many of them huge, and not one of them could fund a trial for Tasigna? They couldn't team up if they didn't want to put all of those research dollars in one basket?
QUOTE] Feel the same as you, couldn't agree more......... |
||
Reply With Quote |
"Thanks for this!" says: | olsen (11-01-2016) |
10-30-2016, 06:49 PM | #5 | ||
|
|||
Member
|
Another company that you may want to follow is Proclara biosciences. They claim to have a single drug that eliminates misfolded protein in multiple Neuro illnesses. They are currently in phase 1a clinical trial. They used to be known as macrophage.
Proclara Biosciences |
||
Reply With Quote |
10-30-2016, 07:43 PM | #6 | ||
|
|||
Member
|
Quote:
|
||
Reply With Quote |
10-31-2016, 07:40 AM | #7 | ||
|
|||
Member
|
|
||
Reply With Quote |
10-31-2016, 09:21 PM | #8 | |||
|
||||
Member
|
Quote:
this is an interesting article about that: α-Synuclein binds to TOM2 and inhibits mitochondrial protein import in Parkinson’s disease | Science Translational Medicine
__________________
Sim00 Born in 1969, diagnosed PD in 2007, first symptoms 2004. DBS in July 2016. |
|||
Reply With Quote |
"Thanks for this!" says: |
12-03-2016, 05:13 PM | #9 | ||
|
|||
Junior Member
|
If Tasigna gets approved for Alzheimer's as both safe and effective, if preliminary trials show success with Parkinson's, could it then be prescribed as an off-label drug for Parkinson's?
|
||
Reply With Quote |
12-03-2016, 11:27 PM | #10 | ||
|
|||
Member
|
Quote:
If you don't want to wait for the end of the phase 2 trials, or can't find a doctor to prescribe off label, or can't afford this expensive drug, yet still want to take it, then consider volunteering for the multi- center study next year. If you qualify, you can get the drug for free and properly monitored (assuming you don't get the placebo.....). You'll also be helping the whole PD community by moving the science forward. |
||
Reply With Quote |
"Thanks for this!" says: |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Nilotinib - lastest update - not the best news | Parkinson's Disease | |||